Bayer CropScience Limited has announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors also declared an interim dividend of ₹90 per equity share for the Financial Year 2026-27. The results and dividend declaration mark key financial updates for the company’s stakeholders, providing insights into performance and shareholder returns.
Bayer CropScience Announces Q2 FY27 Financials and Interim Dividend
Bayer CropScience Limited has disclosed its unaudited financial results for the quarter and the six months ended September 30, 2026. The company’s Board of Directors, in a meeting held on November 3, 2026, approved these results, which were prepared in accordance with Indian Accounting Standard 34.
Financial Highlights for Q2 FY27
For the quarter ended September 30, 2026, Bayer CropScience reported a Profit Before Tax of ₹2,114 million and a Profit for the period/year of ₹1,662 million. The total income for the quarter stood at ₹12,641 million. The company’s revenue from operations was ₹12,507 million, with other income contributing ₹134 million.
During the same period, total expenses amounted to ₹10,527 million. The company’s equity share capital remained stable at ₹449 million, while reserves stood at ₹31,394 million. Earnings per share (basic and diluted, not annualised) for the quarter were ₹36.98.
Six Months Ended September 30, 2026 Performance
For the six months ended September 30, 2026, the Profit Before Tax reached ₹6,135 million, and the Profit for the period/year was ₹4,878 million. Total income for this period was ₹31,880 million, with revenue from operations at ₹30,857 million. Total expenses for the six months were ₹25,745 million.
The consolidated equity share capital and reserves as of September 30, 2026, were ₹449 million and ₹31,394 million respectively. The earnings per share (basic and diluted, not annualised) for the six months were ₹108.54.
Interim Dividend Declaration
A significant announcement from the Board of Directors is the declaration of an interim dividend. An amount of ₹90 per equity share of ₹10 each has been declared for the Financial Year 2026-27. This interim dividend is scheduled to be paid on Monday, November 30, 2026, to shareholders whose names appear in the Register of Members as of the record date, which is Thursday, November 12, 2026. The total value of this dividend payout amounts to ₹4,045 million for the issued equity shares.
Balance Sheet Overview
As of September 30, 2026, the company’s total assets stood at ₹55,372 million, comprising non-current assets of ₹7,703 million and current assets of ₹47,669 million. Total equity was ₹31,843 million, with liabilities amounting to ₹23,529 million.
Cash Flow Statement Insights
The cash flow statement for the six months ended September 30, 2026, shows that cash used in operating activities was ₹6,316 million. Cash generated from investing activities was ₹83 million, while cash used in financing activities amounted to ₹3,209 million. The net decrease in cash and cash equivalents for the period was ₹9,442 million, resulting in a closing balance of ₹4,704 million.
The company’s business is primarily in the “Agri Care” segment and is seasonal in nature. The unaudited financial results have been subjected to a limited review by the statutory auditors, Deloitte Haskins & Sells LLP.
Source: BSE
